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Abstract
Host defence against infection requires a range of innate and adaptive immune responses that may lead to tissue damage.
Such immune-mediated pathologies can be controlled with appropriate T regulatory (Treg) activity. The aim of the present
study was to determine the influence of gut microbiota composition on Treg cellular activity and NF-kB activation
associated with infection. Mice consumed the commensal microbe Bifidobacterium infantis 35624 followed by infection with
Salmonella typhimurium or injection with LPS. In vivo NF-kB activation was quantified using biophotonic imaging.
CD4
+CD25
+Foxp3
+ T cell phenotypes and cytokine levels were assessed using flow cytometry while CD4
+ T cells were
isolated using magnetic beads for adoptive transfer to naı ¨ve animals. In vivo imaging revealed profound inhibition of
infection and LPS induced NF-kB activity that preceded a reduction in S. typhimurium numbers and murine sickness
behaviour scores in B. infantis–fed mice. In addition, pro-inflammatory cytokine secretion, T cell proliferation, and dendritic
cell co-stimulatory molecule expression were significantly reduced. In contrast, CD4
+CD25
+Foxp3
+ T cell numbers were
significantly increased in the mucosa and spleen of mice fed B. infantis. Adoptive transfer of CD4
+CD25
+ T cells transferred
the NF-kB inhibitory activity. Consumption of a single commensal micro-organism drives the generation and function of
Treg cells which control excessive NF-kB activation in vivo. These cellular interactions provide the basis for a more complete
understanding of the commensal-host-pathogen trilogue that contribute to host homeostatic mechanisms underpinning
protection against aberrant activation of the innate immune system in response to a translocating pathogen or systemic
LPS.
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Introduction
Mechanisms of host protection by commensal organisms against
infection vary depending on the nature of the pathogenic
challenge. They range from mutual competition for nutrients
and for microbial niches, to the production of specific anti-
microbial peptides [1,2]. In addition, there is emerging evidence
for engagement of host immune responses by commensal
organisms [3,4].
The host response to infection is characterised by innate and
acquired cellular and humoral immune reactions, designed to limit
spread of the offending organism and to restore organ homeosta-
sis. However, to limit the aggressiveness of collateral damage to
host tissues, a range of regulatory constraints may be activated.
Regulatory T cells (Treg) serve one such mechanism [5]. These
are derived from the thymus but may also be induced in peripheral
organs, including the gut mucosa [6,7]. CD103
+ dendritic cells
within the mucosa are largely responsible for the conversion of
Tregs which is a TGF-b and retinoic acid dependent process [8,9].
The gastrointestinal specific environmental factors that contribute
to dendritic cell conversion of Tregs is likely due in part to the
presence of large numbers of commensal microbes. For example,
encounter with specific experimental microbes within the murine
gut, has been shown to drive the development of mucosal Tregs
which is associated with attenuation of inflammation in a murine
model of colitis [10]. However, it is unclear whether enhancement
of Treg activity by commensal organisms contributes to protection
of the host from mucosal damage and systemic inflammation
associated with infection by invasive pathogens.
Innate pro-inflammatory signalling in response to microbial
exposure is mediated by activation of transcription factors, such as
NF-kB, resulting in the transcription of a battery of effector
molecules contributing to host defence and inflammation [11]. A
number of bacterial products have been identified which directly
block activation of the NF-kB pathway in epithelial cells via a
range of novel mechanisms including the blockade of Ik-B poly-
ubiquination by non-pathogenic Salmonella strains [12] or the
enhancement of NF-kB export from the nucleus by Bacteroides
thetaiotaomicron [13]. However, these molecular events are likely to
be restricted to the gastrointestinal mucosa where direct
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cellular mechanisms permitting prokaryotic modulation of NF-
kB activation following infection in cells outside the gastrointes-
tinal tract is less clear.
The purpose of the present study was: (a) to determine if
bacterial signalling from the lumen of the murine gut after feeding
with a well characterised commensal/probiotic could impact in vivo
activation of the pro-inflammatory transcription factor NF-kB
following infection thereby limiting infection-associated inflamma-
tory injury; (b) examine the mechanism of such protective
regulation by assessing Treg cellular activity in probiotic-fed mice
and by adoptive transfer of T cells into naı ¨ve non-fed animals. The
results show that the putative probiotic/commensal organism
drives Treg activity which limits the pro-inflammatory response to
invasive salmonella infection via down-regulation of NF-kB
activation.
Results
Impact of B. infantis on the pro-inflammatory response to
S. typhimurium
Mice consuming B. infantis were protected from the effects of
infection with S. typhimurium. Biophotonic imaging of in vivo NF-kB
activation illustrated a significant difference just four hours
following infection (Figure 1A). B. infantis-fed animals exhibited a
less pronounced activation of the in vivo NF-kB response compared
to the NF-kB response to infection in placebo-fed controls. This
suppressed pro-inflammatory response persisted for the remainder
of the study period (Figure 1B). Murine clinical scores were not
significantly different until 7 days after the initial infection at which
stage B. infantis-fed animals were significantly better that placebo-
fed controls (Figure 2A) Similarly, systemic pathogen numbers
were not different between the groups until 6 days after infection
(Figure 2B). Therefore, B. infantis attenuation of NF-kB activation
in vivo precedes a reduction in S. typhimurium disease severity and
systemic translocation.
B. infantis reduces the in vivo NF-kB response to LPS
In agreement with the results above suggesting a systemic anti-
inflammatory effect of B. infantis consumption on S. typhimurium-
induced inflammatory damage, in vivo imaging of the pro-
inflammatory transcription factor NF-kB in response to LPS
alone demonstrated significantly less activity in mice-fed B. infantis
four hours after LPS injection (Figure 3A). In order to identify the
sites at which NF-kB activity was being suppressed, we removed
the small intestine, large intestine, liver and spleen from each
animal and quantified NF-kB activity for each organ individually
(Figure 3B). NF-kB activation within the small intestine, liver and
spleen (but not the colon) was significantly reduced in B. infantis-fed
animals (Figure 3C).
B. infantis consumption reduces pro-inflammatory
cytokine secretion
In order to further characterise the impact of NF-kB
suppression on the host inflammatory response, cytokine produc-
tion by isolated Peyer’s patch and spleen-derived cells was
assessed, in vitro, following anti-CD3/CD28 stimulation (lympho-
cyte response) or LPS stimulation (innate TLR-4 response)
immediately prior to S. typhimurium infection (Day 0) or four days
(Day 4) after infection.
CD3/CD28 stimulation of Peyer’s patch cells resulted in
secretion of IFN-c, TNF-a and IL-10 with no differences noted
between placebo-fed controls or B. infantis-fed test animals prior to
Salmonella infection (Figure 4A). However, four days of S.
typhimurium infection was associated with enhanced release of
IFN-c, TNF-a and IL-10 by anti-CD3/CD28 stimulated Peyer’s
patch cells in placebo-fed animals but not in animals consuming B.
infantis. In vitro stimulation of Peyer’s patch cells with LPS yielded
cytokine responses below the assay detection limit and were not
examined further (results not shown).
CD3/CD28 stimulation of splenocytes resulted in secretion of
IFN-c, TNF-a and IL-10 with low levels of IL-6 and MCP-1
(Figure 4B). In agreement with the Peyer’s patch results, no
differences in the cytokine secretion patterns were noted for in vitro
stimulated splenocytes from placebo or B. infantis treated mice
prior to infection. However, the anti-CD3/CD28 stimulated IFN-
c and IL-10 response was significantly attenuated following
Salmonella infection in the B. infantis-fed animals. LPS stimulated
splenocytes released comparable amounts of cytokine from the two
groups of animals prior to infection but four days following
Salmonella translocation, LPS stimulated TNF-a, IL-6 and MCP-
1 release was significantly less in the B. infantis-fed animals
(Figure 4C).
Dendritic cell CD80 expression is altered by B. infantis
consumption
Presentation of antigen by dendritic cells to naı ¨ve T cells
requires the expression of co-stimulatory molecules such as CD80
for effective maturation and clonal expansion of the interacting T
cells. We examined the percentage of mature dendritic cells
(CD11c
+MHCII
+) expressing CD80 in both the Peyer’s patch and
spleen of placebo and B. infantis-fed animals. Surprisingly, fewer
Peyer’s patch dendritic cells co-express CD80 when isolated from
B. infantis-fed animals (Figure 5A). Dendritic cell CD80 expression
increases in the Peyer’s patches of all Salmonella infected animals
but remains significantly less in the B. infantis-fed mice. Splenocyte
dendritic cell CD80 expression is similar in both groups of un-
infected mice but is significantly up-regulated with Salmonella
infection only in the placebo group (Figure 5B).
Author Summary
The normal response to infection is rapid and effective
clearance of pathogenic microbes. However, this immune
response may occasionally cause collateral inflammatory
damage to host tissue and in severe cases, such as
systemic sepsis, results in organ failure. Various cellular
mechanisms, including regulatory T cells, protect against
aggressive immune responses. However, environmental
agents which promote regulatory T cells are not well
understood. We and others have previously shown that
non-pathogenic or commensal micro-organisms can pro-
tect the host from aberrant pro-inflammatory activity
within the gut, but the influence of these microbes on
regulatory T cells in the context of systemic infection has
not been examined. In this study, we demonstrate that
consumption of a single commensal bacterium induces
regulatory T cells in vivo which protect the host from
pathogen-induced inflammatory responses by limiting
activation of the pro-inflammatory transcription factor
NF-kB via the toll-like receptor 4 (TLR-4) pathway. This
report conclusively demonstrates a cellular and molecular
basis for the commensal-host-pathogen trilogue resulting
in enhanced protection from systemic infection whilst
limiting pro-inflammatory damage mediated by activation
of the innate immune system.
Tregs Limit NF-kB Activation In Vivo
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numbers of T regulatory cells
The percentage of CD4
+ T cells expressing the a chain of the
IL-2 receptor, CD25, was examined in both Peyer’s patch and
spleen of un-infected and Salmonella infected animals. We noted a
significant increase in the percentage of CD4
+ cells co-expressing
CD25 in the Peyer’s patch of animals fed B. infantis, particularly
following Salmonella infection (Figure 6A). A statistical significant
inverse correlation was noted between the percentage of CD80
+
activated dendritic cells and CD4
+CD25
+ T cells within the
Peyer’s patch suggesting a link between dendritic cell co-
stimulatory molecule expression and T regulatory cell induction
(r
2=0.419, p=0.01). This does not prove a causal relationship but
simply implies that these cellular events may both be associated
with bifidobacterial consumption.
There are also significantly more CD4
+CD25
+ cells in the
spleen of animals fed B. infantis (Figure 6B). The majority (.75%)
of the spleen-derived CD4
+CD25
+ T cells also stained positive for
the Treg transcription factor Foxp3 (Figure 6C & 6D). Finally,
when these T cells were isolated and examined in vitro, the
CD4
+CD25
+ T cells suppressed proliferation of naı ¨ve CFSE
labelled CD4 cells while depletion of the CD25
+ subset cells
removed the suppressive effect (Figure 6E).
CD4+CD25+ T cell adoptive transfer reduces in vivo NF-
kB activation
In order to examine the hypothesis that NF-kB suppression is
mediated by bifidobacterial induction of Tregs, we isolated CD4
+
T cells from placebo or B. infantis-fed animals and adoptively
transferred these to naı ¨ve animals. Following LPS injection, NF-
kB activation was significantly less in animals that received CD4
+
T cells from B. infantis-fed mice compared to animals that received
CD4
+ T cells from placebo-fed mice (Figure 7A & 7B). Depletion
of the CD25
+ subset from the T cell population removed the
suppressive effect while adoptive transfer of CD25
+ cells alone was
sufficient to reduce NF-kB activation in situ and release of TNF-a
from cultured splenocytes (Figure 7C & 7D).
Discussion
This report illustrates at a cellular and molecular level the
impact of the commensal microbiota on host immune defence and
Figure 1. B. infantis attenuates NF-kB activation in vivo in response to S. typhimurium infection. (A) A representative in vivo image
illustrates that NF-kB activation in NF-kBlux transgenic mice four hours following S. typhimurium infection is attenuated when an animal is pre-fed B.
infantis; (B) In vivo NF-kB activation in B. infantis-fed animals was significant reduced compared to NF-kB activation in placebo-fed controls (n=6/
group). *p,0.05 versus placebo.
doi:10.1371/journal.ppat.1000112.g001
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commensal organism, Bifidobacterium infantis 35624, resulted in
the induction of Treg cells which protected the host from excessive
inflammation during the course of infection as evidenced by
reduced pro-inflammatory cytokine production, reduced T cell
proliferation, reduced dendritic cell co-stimulatory molecule
expression and attenuation of NF-kB activation. The role of Treg
cells in this biological process was conclusively demonstrated by
the adoptive transfer of CD4
+CD25
+ T cells into naı ¨ve mice which
was sufficient to suppress NF-kB activation in response to LPS
injection.
Treg cells have been well described as suppressors of auto-
reactive T cells [14,15] and suppress inflammatory disease in a
wide range of murine models including experimental autoimmune
encephalomyelitis [16], inflammatory bowel disease [17], bacte-
rial-induced colitis [18], collagen-induced arthritis [19], type I
diabetes [20], airway eosinophilic inflammation [21], graft-vs-host
disease [22] and organ transplantation [23]. Similarly, supple-
mentation of the microbiota with certain commensal micro-
organisms has also shown anti-inflammatory effects in a number of
these models [24–27]. It is tempting to speculate that induction of
Treg cells by the commensal microbiota could be partly
responsible for the observed anti-inflammatory activity in these
model systems. However, the role of commensal bacteria in
controlling the pro-inflammatory response associated with infec-
tion is less clear. Indeed, the activity of Treg cells in the models
above is primarily mediated by suppression of antigen specific
immune responses while our studies demonstrate an effect on
innate immune activation, in particular activation through the
TLR-4 pathway. It has been recently suggested that CD4
+CD25
+
T cells induce an alternative activation pathway in monocytes
associated with a diminished capacity to respond to LPS which
supports the findings of this study [28,29].
The host cellular mechanisms underpinning induction of Treg
cells by the commensal microbiota was not examined in this study
but is hypothesised to be mediated in part by dendritic cells.
Following encounter with pathogenic or commensal microbes,
dendritic cells provide instructive signals that influence T cell
differentiation into Th1, Th2 or regulatory phenotypes [30,31].
Multiple reports implicate dendritic cells in the induction of
tolerance and regulatory cells to the commensal microbiota [32].
In vitro co-incubation of human mesenteric lymph node derived
Figure 2. B. infantis reduces S. typhimurium disease severity and systemic translocation. (A) Macroscopic clinical scoring of mice infected
with S. typhimurium reveals a significant reduction in B. infantis pre-fed mice disease symptoms 8 days following initial infection (n=10/group); (B) S.
typhimurium numbers were reduced in the spleens and livers of B. infantis fed mice 6 days following infection (n=18/group). *p,0.05 versus placebo.
doi:10.1371/journal.ppat.1000112.g002
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TGF-b, but not TNF-a or IL-12 [33]. Both IL-10 and TGF-b are
important cytokines in directing naı ¨ve T cell maturation down a
regulatory pathway. In addition, in vitro co-incubation of monocyte
derived dendritic cells with certain commensal lactobacilli strains
have been shown to drive the in vitro generation of IL-10 producing
T cells which inhibit bystander T cell proliferation [34].
Not all commensal micro-organisms may be equally effective in
driving T regulatory cell activity. Co-incubation of a panel of
commensal bacteria with peripheral blood mononuclear cells
(PBMCs) in vitro resulted in varying amounts of IL-10 production
suggesting that strain specific characteristics, as yet largely
undefined, drive regulatory cytokine production [35]. Commen-
sal-induced protection from infection may also involve additional
strain-specific mechanisms of action including the production of
selective anti-microbial compounds [2]. The relative importance
of microbe-microbe and microbe-host interactions in protecting
the host from infection is likely to also depend on the nature of the
infectious organism. However, the mechanism underpinning the
suppressed pro-inflammatory response to a translocating microbe
described in this study strongly implicate Tregs as modulation of
the host pro-inflammatory response precedes the difference in
systemic salmonella recovery. In addition, LPS injection models
systemic infection with a gram negative pathogen and suppression
of the host response to LPS alone can not be explained by other
mechanisms such as competition within the intestine or activation
of pathogen-specific effector T cells.
This report clearly demonstrates that activation of the host
innate pro-inflammatory pathways to a translocating infectious
agent, or systemic LPS, can be influenced by the commensal
microbiota via the induction of Treg cells. NF-kB is a key
transcription factor that is central to the observed anti-inflamma-
tory effect and improved regulation of NF-kB is an important
therapeutic target in a wide range of pro-inflammatory states,
including sepsis [36]. This report supports the clinical evaluation
of appropriately selected probiotic/commensal micro-organisms
for the promotion of CD4
+CD25
+Foxp3
+ T cells in vivo in order
to control the innate inflammatory cascade to translocating
microbes.
Materials and Methods
Animal models
Balb/c mice were obtained from Charles River Laboratories
(Bicester, UK) and bred in-house for bifidobacterial feeding and
salmonella infection studies. NF-kBlux transgenic mice on a
Figure 3. NF-kB activation is suppressed in LPS-injected mice when pre-treated with B. infantis. (A) Whole body imaging of NF-kBlux mice
4 hours following LPS injection reveals suppressed NF-kB activation in the B. infantis-fed animals. (B) Organs were removed for imaging purposes and
a representative image is illustrated. (C) The mean increase in NF-kB activation following i.p. injection of LPS is significantly less in the ileum, spleen
and liver of B. infantis-fed mice. *p,0.05 versus placebo, n=5/group.
doi:10.1371/journal.ppat.1000112.g003
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Laboratories (Wilmington, USA) and bred in-house. Mice were
housed under barrier maintained conditions within the biological
services unit, University College Cork (UCC). All animal
experiments were approved by the UCC animal ethics committee
and experimental procedures were conducted under appropriate
license from the Irish government.
Bacterial strains
Bifidobacterium infantis 35624 (B. infantis) was isolated from
healthy human gastrointestinal tissue and its use as a probiotic
organism has been previously reported [37,38]. B. infantis was
routinely cultured anaerobically for 48 hours in deMann,
Rogosa and Sharpe medium, MRS, (Oxoid, Basingstoke,
UK) supplemented with 0.05% cysteine (Sigma, Dublin,
Ireland). Salmonella typhimurium UK1 (S. typhimurium)w a s
provided by Roy Curtis (Washington University, US) and
was routinely cultured aerobically at 37uCf o r2 4 h o u r si n
tryptic soya broth (Oxoid).
Animal model feeding studies
B. infantis was administered to all animals as a freeze-dried
powder reconstituted in water at approximately 1610
9 colony
forming units/day/animal. Mice consumed the commensal
micro-organism in their drinking water ad libitum for at least 3
weeks prior to salmonella infection. Challenge with S. typhimurium
was performed as described by Wilems-Riesenberg et al [39,40].
Briefly, S. typhimurium was grown overnight, pelleted and
resuspended in buffered saline gelatin (0.85% NaCl, 0.01%
gelatin and 2.2 mM KH2PO4). Inoculation with Salmonella was
performed by injecting 20 ml of a single inoculum of the
Salmonella suspension behind the murine incisors with a
micropipette tip in a flexible film isolator. A dose of 1610
6 S.
typhimurium viable cells was chosen as the optimal dose for these
studies as higher doses did not result in increased recovery of
viable cells from the murine liver and spleen while lower doses
did not yield reproducible or consistent bacterial counts from
systemic sites [41]. Animals were monitored for disease
progression using a clinical scoring scale. This scale scored
Figure 4. Cytokine production is suppressed in S. typhimurium-infected mice when pre-treated with B. infantis. Cytokine release by
isolated cells was examined immediately prior to S. typhimurium infection (Day 0) or four days (Day 4) after infection. (A) In vitro cytokine production
by anti-CD3/CD28 stimulated Peyer’s patch cells is significantly reduced in S. typhimurium infected mice when fed B. infantis with no differences being
observed prior to infection; (B) In vitro IFN-c and IL-10 production by anti-CD3/CD28 stimulated spleenocytes is significantly increased in placebo-fed
animals following S. typhimurium infection. However, this increase was not observed in animals consuming B. infantis. TNF-a levels were similar for
the two groups; (C) LPS stimulated splenocytes released comparable amounts of cytokine from the two groups of animals prior to infection but four
days following Salmonella translocation, LPS stimulated TNF-a, IL-6 and MCP-1 release was significantly less in the B. infantis-fed animals. *p,0.05
versus placebo, n=8/group at each timepoint.
doi:10.1371/journal.ppat.1000112.g004
Tregs Limit NF-kB Activation In Vivo
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in Table 1.
Salmonella titres were calculated in liver and spleen using
quantitative real-time Polymerase Chain Reaction (qPCR).
Briefly, liver and spleen samples were transferred to sterile
stomacher bags and mixed with 1X PBS (Gibco BRL, UK) and
homogenised using mechanical means. Samples were stored at-
20uC until analysis. DNA extractions were performed using the
Qiagen DNAeasy Tissue Kit (Qiagen,West Sussex, UK)
according to manufacturers instructions. Isolated DNA concen-
trations were ascertained using the Nanodrop (Thermo Scien-
tific) and standardised to 20 ng DNA per reaction. LightCycler
Real-time PCR was used to quantify Salmonella genomic DNA
concentrations using the following primers INVA2_R: 59-TGT
CCT CCG CTC TGT CTA CTT -39 INVA2_L: 59-ATC AAC
AAT GCG GGG ATC T -39 (76 bp product), and Probe library
#9 (Roche Diagnostics). All primers were synthesized by MWG
Biotech, (Ebersberg Germany). PCR amplifications were carried
out in glass capillaries (Roche Diagnostics) in a total final volume
of 20 ml using a LightCycler (Roche Diagnostics). A standard
curve was generated by adding DNA from 10 fold dilution series
of purified Salmonella genomic DNA. This was used to calculate
Salmonella concentration. The LightCycler software identified
the Ct (threshold cycle number) values and the concentrations of
Salmonella were calculated by comparing Ct values to the
crossing point values of the linear regression line of the standard
curve.
In vivo assessment of NF-kB signalling
In vivo imaging of NF-kBlux transgenic mice were performed by
firstly anaesthetizing the mice with isoflurane (Inhalation Anaes-
thetic, Abbot Laboratories Ltd., Kent, UK). D-luciferin (120 mg/
kg; Biothema AB, Handen, Sweden) dissolved in 200 ul PBS,
pH 7.8, was injected i.p. Immediately afterwards the mice were
placed in a ventral recumbent position in a light-sealed chamber in
the In Vivo Imaging System (IVIS) chamber (Xenogen, Alameda,
USA) and imaged continuously for 5 minutes with a medium
sensitivity setting starting 2 minutes after the injection of D-
luciferin. A reference black and white image of the animal was
taken in low light conditions then a sensitive cooled charge-
coupled device camera collected the photons emitted. Photons
were quantified using Living Image software (Xenogen) and the
luciferase activity quantified as the amount of light emitted per
second per cm
2 from the animal/organs. The pseudo-colored
images represent light intensity (red is the strongest and violet is
the weakest).
Individual organs to be imaged were excised from the mice
5 minutes following D-luciferin administration. Organs were
placed in a culture dish and immediately imaged, again with an
acquisition integration time of 5 minutes. Organs examined were
the spleen, liver, small intestine and colon.
In vitro culture and cytokine measurement
Spleens were aseptically removed from all animals and a single
cell suspension generated using mechanical means. In addition,
the small intestine of mice were removed and the lymphoid
follicles of the Peyer’s patches were carefully dissected from the
intestinal serosal side with curved scissors and collected into 5 ml
of PBS containing 1 mM EDTA and collagenase (Sigma).
Following incubation in a shaking oven at 37uC for 20 mins, the
collected patches were placed between two sterile glass slides and
crushed. This cell suspension was centrifuged (100 g610 min) and
the pellet was resuspended and diluted in Dulbecco’s modified
eagle medium (DMEM). Single cell suspensions were seeded, in
duplicate, in 24 well tissue culture plates (Sarstedt, Newton, USA)
at 1610
6 cells per well. Single cell suspensions were stimulated for
72 hours with anti-CD3 and anti-CD28 antibodies (BD Biosci-
ences, Oxford, UK), LPS (Sigma) or remained non-stimulated to
assess background cytokine secretion. Following a 72-hour
incubation period (@37uC and 5% CO2 humidified atmosphere)
all supernatants were harvested for cytokine analysis. These were
aliquoted and stored at 270uC for analysis of cytokine production
in batches. IL-6, IL-10, IL-12, MCP-1, TNF-a and IFN-c levels
were quantified using cytometric bead arrays (BD). Cytokine levels
were measured using a BD FacsCaliber flow cytometer and
analysis was carried out using the BD CellQuest software and BD
CBA Software.
Proliferation assay
CD4 T cell proliferation was measured using the CellTrace
TM
CFSE Cell Proliferation Kit (Invitrogen). Briefly, CD4
+ T Cells were
positively selected (.98% purity) from spleens using CD4 MicroBe-
ads (Miltenyi Biotech, Bergisch Gladbach, Germany) and an
autoMACS separator. These cells were labeled with CFSE and
incubated in vitro for three days with anti-CD3 and anti-CD28
stimulation (BD). Concurrently, CD4
+ T cells were isolated from B.
infantis-fedmiceasoutlined aboveandsubdividedintoCD4
+CD25
+
and CD4
+CD25
2 populations using microbeads (Miltenyi). These
cells were not CFSE labeled and were co-incubated with the labeled
Figure 5. Dendritic cells are less activated in B. infantis-fed mice.
(A) The percentage of CD11c
+MHC II
+ mature dendritic cells staining
positive for the co-stimulatory molecule CD80 are reduced in the
Peyer’s patch of B. infantis-fed mice prior to and during S. typhimurium
infection. (B) Splenocyte dendritic cell CD80 expression is similar in both
groups of un-infected mice but is significantly up-regulated with
Salmonella infection only in the placebo group. *p,0.05 versus
placebo, n=6–9 animals per group per timepoint.
doi:10.1371/journal.ppat.1000112.g005
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was measured by flow cytometry.
Cellular phenotypes
Single cell suspensions from the Peyer’s patch and spleens of
mice were generated as outlined above. Monoclonal antibodies to
CD3, CD4, CD11c, CD25, CD80 and MHC II (BD) were used to
label cells for T cell subset analysis (CD3, CD4 and CD25) and
dendritic cell co-stimulatory molecule expression (CD11c, MHC
II and CD80). Antibodies to the transcription factor Foxp3
(eBioscience, San Diego, USA) were used to label permeabilised
cells in representative experiments. Cellular phenotypes were
measured using a BD FacsCaliber flow cytometer and analysis was
carried out using the BD CellQuest software.
Impact of CD4
+CD25
+ T cell adoptive transfer on NF-kB
activation
In vivo assessment of NF-kB activation was determined following
feeding of wildtype (NFkB
2/2) mice with either B. infantis or
placebo for three weeks. The spleens were removed and CD4
+ T
Cells were positively selected (.98% purity) using the method
outlined above. Adoptive transfer of 1610
6 CD4
+ T cells/ml into
NF-kBlux
+/+ transgenic mice (n=6/grp) was performed by i.p.
injection. 8 days later 3 mg/kg LPS (Sigma) was injected i.p. and
NF-kB measurements taken after 4 hours. In vivo images were
captured by the IVIS in the same manner as described above.
In order to determine the CD4
+ T cell subset responsible for
mediating this effect, CD4 T cells from B. infantis-fed animals were
further isolated into CD4
+/CD25
+ and CD4
+/CD25
2 subpopula-
tions as per manufactures protocol (Miltenyi Biotech, Bergisch
Gladbach, Germany). Adoptive transfer of 1.5610
5 CD4
+/CD25
+
T cells/ml or 8.5610
5 CD4
+/CD25
2 Tc e l l s / m li n t on a ı ¨ve mice
(n=5/grp) was performed by i.p. injection. 8 days later 3 mg/kg
LPS (Sigma) was injected i.p. and animals were sacrificed after
4 hours and tissues harvested. Intestinal NF-kB p65 activation was
measured in nuclear extracts using an NF-kB p65 ELISA-based
transcription factor assay kit (TransAM Assay, Active Motif,
Germany) according to the manufacturer’s protocol. TNF-a release
fromLPS stimulated splenocytes wasmeasured using flow cytometry
as outlined above.
Figure 6. Bifidobacterium infantis consumption increases Treg numbers and activity in S. typhimurium infected mice. (A) There is a
significant increase in the percentage of CD4
+ cells co-expressing CD25 in the Peyer’s patch of animals fed B. infantis, particularly following
Salmonella infection; (B) There are also significantly more CD4
+CD25
+ cells in the spleen of animals fed B. infantis; (C) A representative flow cytometry
dot-plot illustrates that the majority of the CD25
+ cells within the spleen also stain positive for Foxp3 which is graphed for B. infantis-fed animals in
(D); (E) CD4
+CD25
+ T cells suppressed proliferation of naı ¨ve CFSE labelled CD4
+ cells while depletion of the CD25
+ subset cells removed the
suppressive effect. *p,0.05 versus placebo.
doi:10.1371/journal.ppat.1000112.g006
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GraphPad Prism software utilising 2Way-ANOVA with Bon-
ferroni’s Post-test was used to determine statistical significance.
LightCycler data was analyzed using Pearson’s correlation
coefficient and students T-tests were used to determine differences
between groups.
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